Treating sexual desire disorders with flibanserin
View Patent ↗The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
1. A method of treating lack of sexual desire or loss of sexual desire in a patient, comprising administering a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof to said patient to treat lack of sexual desire or loss of sexual desire in said patient.
2. The method according to claim 1 , wherein the patient is female.
3. The method according to claim 1 , wherein the patient is male.
4. The method according to claim 1 , wherein the amount administered is between about 0.1 mg and 400 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
5. The method according to claim 1 , wherein the amount administered is between about 1 mg and 300 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
6. The method according to claim 1 , wherein the amount administered is in a dosage unit containing between about 0.01 mg and 100 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
7. The method according to claim 1 , wherein the amount administered is in a dosage unit containing between about 0.1 mg and 50 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
8. A method of treating a lack of sexual desire in a patient, comprising administering a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof to said patient to treat lack of sexual desire in said patient.
9. The method according to claim 8 , wherein the patient is female.
10. The method according to claim 8 , wherein the patient is male.
11. The method according to claim 8 , wherein the amount administered is between about 2 mg and 200 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
12. The method according to claim 8 , wherein the amount administered is between about 0.1 mg and 100 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
13. The method according to claim 8 , wherein the amount administered is in a dosage unit containing about 150 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
14. A method of treating loss of sexual desire in a patient, comprising administering a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof to said patient to treat loss of sexual desire in said patient.
15. The method according to claim 14 , wherein the patient is female.
16. The method according to claim 14 , wherein the patient is male.
17. The method according to claim 14 , wherein the amount administered is between about 0.1 mg and 400 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
18. The method according to claim 14 , wherein the amount administered is in a dosage unit containing about 100 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
19. The method according to claim 14 , wherein the amount administered is in a dosage unit containing about 80 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof.
20. The method according to claim 14 , wherein the amount administered is in a dosage unit containing about 50 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof.